|
Real-time Estimate
Cboe BZX
00:12:57 15/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2.275 USD | -3.60% |
|
-7.52% | +26.39% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Quotes 5-day view: Protalix BioTherapeutics, Inc.
Delayed Quote NYSE
| 10/08/2026 | 11/08/2026 | 12/08/2026 | 13/08/2026 | 15/08/2026 | |
|---|---|---|---|---|---|
| Last | US$2.480 | US$2.430 | US$2.620 | US$2.360 | US$2.275 |
| Volume | 773,425 | 373,852 | 2,012,469 | 2,001,846 | 510,646 |
| Change | +0.81% | -2.02% | +7.82% | -9.92% | -3.60% |
| Opening | US$2.480 | US$2.470 | US$2.490 | US$2.640 | US$2.360 |
| High | US$2.500 | US$2.480 | US$2.705 | US$2.640 | US$2.360 |
| Low | US$2.410 | US$2.410 | US$2.400 | US$2.320 | US$2.260 |
Performance
| 1 day | -3.60% | ||
| 1 week | -7.52% | ||
| Current month | -4.01% | ||
| 1 month | -1.52% | ||
| 3 months | +13.75% | ||
| 6 months | -23.66% | ||
| Current year | +26.39% | ||
| 1 year | +49.67% | ||
| 3 years | +14.32% | ||
| 5 years | +72.35% | ||
| 10 years | -64.89% |
Volumes
marketsDaily volume
510,646
Estimated daily volume
1,315,692
Avg. Volume 20 sessions
688,823
Daily volume ratio
1.91
Avg. Volume 20 sessions USD
1,567,072.33
Record volume 1
191,289,000
Record volume 2
19,414,390
Record volume 3
12,716,823
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (USD)
190,149,075
Net sales (USD)
52,744,000
Number of employees
226
Sales / Employee (USD)
233,381
Free-Float
96.12 %
Free-Float capitalization (USD)
182,775,482
Average Daily Capital Traded
0.82%
Indicators
Moving average 5 days
2.47
Moving average 20 days
2.388
Moving average 50 days
2.268
Moving average 100 days
2.198
Price spread / (MMA5)
+8.57%
Price spread / (MMA20)
+4.99%
Price spread / (MMA50)
-0.31%
Price spread / (MMA100)
-3.38%
STIM
RSI 9 days
73.62
RSI 14 days
69.06
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.60% | -7.52% | +49.67% | +14.32% | 190M | |
| -1.77% | -0.19% | +72.91% | +119.97% | 1,078B | |
| -0.61% | +0.30% | +48.83% | +49.93% | 632B | |
| -0.45% | +1.21% | +21.66% | +63.54% | 443B | |
| -1.99% | -3.32% | +41.98% | +34.08% | 356B | |
| -1.05% | -2.81% | +24.22% | +34.67% | 289B | |
| -2.12% | -3.67% | -1.09% | +3.11% | 245B | |
| -1.36% | +0.26% | +41.93% | +57.88% | 226B | |
| -1.19% | -3.41% | -9.18% | -52.41% | 204B | |
| -0.31% | +3.48% | +15.82% | +72.64% | 171B | |
| Average | -1.44% | +0.96% | +30.68% | +39.77% | 364.39B | |
| Weighted average by Cap. | -1.26% | +1.30% | +41.45% | +62.23% |
Historical Quotes: Protalix BioTherapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
68913157dcf0ffb743cf.84C3FMdns6lyDAFrrAKyIhXOT_lgEzEpwsPedfTl0_U.mfLVTJEWxuMoTkMD-GTeGnubOY5VXmFar5evI6SAkMel7PJFjwnH7yc1RA
| Date | Price | Volume | Total |
|---|---|---|---|
| 23:54:00 | 2.275 | 100 | 482,233 |
| 23:50:10 | 2.275 | 200 | 482,133 |
| 23:50:10 | 2.275 | 200 | 481,933 |
| 23:50:08 | 2.270 | 100 | 481,733 |
| 23:50:08 | 2.270 | 400 | 481,633 |
| 23:49:29 | 2.275 | 100 | 481,233 |
| 23:49:18 | 2.275 | 100 | 481,133 |
| 23:49:11 | 2.270 | 100 | 481,033 |
| 23:49:11 | 2.270 | 100 | 480,933 |
| 23:49:11 | 2.270 | 100 | 480,833 |
Course Extremes
| 1 week | 2.26 |  | 2.7 |
| 1 month | 2.2 | | 2.7 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.46 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
Monthly variations
Annual variations
| 2026 | +31.11% | ||
| 2025 | -4.26% | ||
| 2024 | +5.62% | ||
| 2023 | +29.93% | ||
| 2022 | +64.72% | ||
| 2021 | -77.09% | ||
| 2020 | +10.67% | ||
| 2019 | +5.47% | ||
| 2018 | -52.96% | ||
| 2017 | +48.58% | ||
| 2016 | -56.37% | ||
| 2015 | -44.57% | ||
| 2014 | -52.70% | ||
| 2013 | -25.05% | ||
| 2012 | +5.27% | ||
| 2011 | -50.60% | ||
| 2010 | +50.76% | ||
| 2009 | +259.78% | ||
| 2008 | -45.88% | ||
| 2007 | -87.48% |
- Stock Market
- Stocks
- PLX Stock
- Quotes Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
